Cargando…

Baseline mineralizing surface determines the magnitude of the bisphosphonate effect on cortical bone mineralization in postmenopausal osteoporotic patients

PURPOSE: To determine the effect of short- or long-term bisphosphonate treatment on cortical bone mineralization density distribution (BMDD). METHODS: BMDD was assessed by quantitative backscatter electron imaging in postmenopausal osteoporosis: in paired transiliac biopsy samples (n=36) at baseline...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misof, B.M., Blouin, S., Lueger, S., Paschalis, E.P., Recker, R.R., Phipps, R., Klaushofer, K., Roschger, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Musculoskeletal and Neuronal Interactions 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601263/ https://www.ncbi.nlm.nih.gov/pubmed/28860420

Ejemplares similares

Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD)
por: Misof, Barbara M., et al.
Publicado: (2019)

No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients
por: Misof, Barbara M., et al.
Publicado: (2020)

Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral
por: Paschalis, E.P., et al.
Publicado: (2011)

Effects of odanacatib on bone matrix mineralization in rhesus monkeys are similar to those of alendronate
por: Misof, Barbara M., et al.
Publicado: (2016)

No evidence of mineralization abnormalities in iliac bone of premenopausal women with type 2 diabetes mellitus
por: Misof, Barbara M., et al.
Publicado: (2022)

Effect of hormone replacement therapy on bone formation quality and mineralization regulation mechanisms in early postmenopausal women
por: Gamsjaeger, S., et al.
Publicado: (2021)

Comparative effects of denosumab or bisphosphonate treatment on bone mineral density and calcium metabolism in postmenopausal women
por: Augoulea, A., et al.
Publicado: (2017)

Eldecalcitol improves chair-rising time in postmenopausal osteoporotic women treated with bisphosphonates
por: Iwamoto, Jun, et al.
Publicado: (2014)

Biomechanical and Bone Material Properties of Schnurri‐3 Null Mice
por: Hofstaetter, Jochen G, et al.
Publicado: (2019)

Bone mineral density changes of lumbar spine and femur in osteoporotic patient treated with bisphosphonates and beta-hydroxy-beta-methylbutyrate (HMB): Case report
por: Tatara, Marcin R., et al.
Publicado: (2017)

Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients: A meta-analysis
por: Fan, Guiyong, et al.
Publicado: (2020)

Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial
por: Kim, Jinyoung, et al.
Publicado: (2022)

Mathematical modeling of the effects of CK2.3 on mineralization in osteoporotic bone
por: Lisberg, A, et al.
Publicado: (2017)

Variables Reflecting the Mineralization of Bone Tissue From Fracturing Versus Nonfracturing Postmenopausal Nonosteoporotic Women
por: Rizzo, Sébastien, et al.
Publicado: (2018)

The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density
por: van der Burgh, Anna C., et al.
Publicado: (2021)

Trajectories of Bone Remodeling Markers and Bone Mineral Density during Treatment with Strontium Ranelate in Postmenopausal Women Previously Treated with Bisphosphonates
por: Lima, Helisane, et al.
Publicado: (2014)

Anxiety Levels Predict Bone Mineral Density in Postmenopausal Women Undergoing Oral Bisphosphonates: A Two-Year Follow-Up
por: Martino, Gabriella, et al.
Publicado: (2021)

Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment
por: Brun, Lucas R, et al.
Publicado: (2014)

Effectiveness of bisphosphonates on bone mineral density in osteopenic postmenopausal women: A systematic review and network meta-analysis of randomized controlled trials
por: Dong, Su-li, et al.
Publicado: (2021)

Osteocyte-specific dentin matrix protein 1: the role of mineralization regulation in low-magnitude high-frequency vibration enhanced osteoporotic fracture healing
por: Li, Meng C. M., et al.
Publicado: (2022)

Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures
por: Kim, Hong Jin, et al.
Publicado: (2023)

Spinal bone mineral density of normal and osteoporotic women in Korea.
por: Koh, S. K., et al.
Publicado: (1992)

Increased zinc accumulation in mineralized osteosarcoma tissue measured by confocal synchrotron radiation micro X‐ray fluorescence analysis
por: Rauwolf, Mirjam, et al.
Publicado: (2016)

Healthy plant-based diet index as a determinant of bone mineral density in osteoporotic postmenopausal women: A case-control study
por: Ghadiri, Marzieh, et al.
Publicado: (2023)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

BISPHOSPHONATE-INDUCED MAXILLOFACIAL OSTEONECROSIS IN OSTEOPOROTIC INDIVIDUALS
por: da Silva Santos, Paulo Sérgio, et al.
Publicado: (2015)

Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study
por: Richards, JB, et al.
Publicado: (2008)

Treatment of bone loss in proximal femurs of postmenopausal osteoporotic women with AGN1 local osteo-enhancement procedure (LOEP) increases hip bone mineral density and hip strength: a long-term prospective cohort study
por: Howe, J.G., et al.
Publicado: (2019)

Effects of Bisphosphonate Therapy on Bone Mineral Density in Boys with Duchenne Muscular Dystrophy
por: Ronsley, Rebecca, et al.
Publicado: (2020)

Vitamin C epigenetically controls osteogenesis and bone mineralization
por: Thaler, Roman, et al.
Publicado: (2022)

Relationship between Bone Mineral Density and Balance Disorders in Osteoporotic Patients
por: Radaei, Fatemeh, et al.
Publicado: (2013)

Bone Mineral Density and Risk of Osteoporotic Fractures in Women with Parkinson's Disease
por: Bystrytska, Maryna, et al.
Publicado: (2020)

The effect of shock waves on mineralization and regeneration of distraction zone in osteoporotic rabbits
por: Özkan, Enes, et al.
Publicado: (2023)

Abstract 41: Effect of zoledronic acid on bone mineral density in Indian postmenopausal osteoporotic women with and without diabetes – A prospective cohort study
por: Merugu, Chandhana, et al.
Publicado: (2022)

Mineral density differences between femoral cortical bone and trabecular bone are not explained by turnover rate alone
por: Lerebours, Chloé, et al.
Publicado: (2020)

Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice
por: Boyanov, Mihail, et al.
Publicado: (2016)

Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
por: Pazianas, Michael, et al.
Publicado: (2010)

Serum bone alkaline phosphatase is a useful marker to evaluate lumbar bone mineral density in Japanese postmenopausal osteoporotic women during denosumab treatment
por: Nakamura, Yukio, et al.
Publicado: (2017)

Combination of Nanoindentation and Quantitative Backscattered Electron Imaging Revealed Altered Bone Material Properties Associated with Femoral Neck Fragility
por: Fratzl-Zelman, N., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9da38a3hesi0j5di08s8e14g2a